Icosapent Ethyl is a synthetic derivate of the omega-3 fatty acid eicosapentaenoic acid (EPA), prescribed as an adjunct to diet to reduce hypertriglyceridemia in adults.

An advisory panel of the US Food and Drug Administration has voted against the expansion of approval for Amarin Corporation Plc's triglyceride-lowering drug Vascepa (icosapent ethyl).The panel ...

The Medicines and Healthcare products Regulatory Agency (MHRA) granted a marketing authorisation for Vazkepa (icosapent ethyl) as a treatment to reduce risk of cardiovascular events in high-risk ...